药用级碳酸锂市场 - 全球产业规模、份额、趋势、机会和预测，依纯度（99%、99% 以上）、应用（缓释、速释）、地区和竞争细分，2020 年至 2030 年预测

2024 年全球药用级碳酸锂市场价值为 1.4589 亿美元，预计到 2030 年将达到 1.5297 亿美元，预测期内的年复合成长率(CAGR) 为 3.75%。近年来，药用级碳酸锂市场显着成长，主要原因是对锂基药物和疗法的需求不断增长。碳酸锂是一种锂盐，在治疗情绪障碍（特别是躁郁症和忧郁症）的药物製剂生产中起着至关重要的作用。

这一市场成长归因于多种因素，包括心理健康意识的提高、老年人口的增加以及对锂在神经科学应用的持续研究。截至 2024 年 6 月，联合国报告称，已有 107 个国家（约占全球温室气体排放量的 82%）承诺净零排放。这项承诺正在刺激对先进储能係统的需求，进而加速碳酸锂市场的成长。药用级碳酸锂市场的稳定成长反映了製药业的扩张和对锂基情绪障碍治疗的日益认可。

有几个关键驱动因素推动了这一成长，例如情绪障碍盛行率的上升、研发活动的增加以及碳酸锂在药物配方中的应用越来越多。该市场扩张的一个重要因素是人们对心理健康问题认识的不断增强。随着围绕心理健康的讨论和旨在应对这些挑战的倡议越来越多，越来越多的人得到诊断，这推动了对包括碳酸锂在内的有效药物的需求。

此外，全球人口老化导致对碳酸锂等药物的需求增加，因为情绪障碍在老年人中更为常见。对锂在神经科学和精神病学领域的潜在应用的持续研究进一步支持了市场的成长。根据世界卫生组织 2022 年 6 月的报告，全球每八人中就有一人患有扰乱思维、情绪调节或行为的精神障碍。

主要市场驱动因素

心理健康意识不断提高

主要市场挑战

副作用和安全问题

主要市场趋势

神经保护应用

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球医药级碳酸锂市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按纯度（99%、99% 以上）
  • 依应用分类（缓释、速释）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美医药级碳酸锂市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第七章：欧洲医药级碳酸锂市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太医药级碳酸锂市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美医药级碳酸锂市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲医药级碳酸锂市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如果有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Arcadium Lithium PLC
• Albemarle Corporation
• Jiangsu Lianhuan Pharmaceutical Co., Ltd.
• American Elements
• Jiangsu Nhwa Pharmaceutical Co., Ltd.
• Panchsheel Organics Ltd (POLTD)
• Blanver

第 15 章：策略建议

第16章 调査会社について・免责事项

The Global Pharmaceutical Grade Lithium Carbonate Market was valued at USD 145.89 million in 2024 and is projected to reach USD 152.97 million by 2030, growing at a compound annual growth rate (CAGR) of 3.75% during the forecast period. The market for pharmaceutical-grade lithium carbonate has seen significant growth in recent years, primarily driven by the increasing demand for lithium-based medications and therapies. Lithium carbonate, a lithium salt, plays a critical role in the production of pharmaceutical formulations used to treat mood disorders, particularly bipolar disorder and depression.

This market growth is attributed to several factors, including rising mental health awareness, the expanding elderly population, and ongoing research into lithium's applications in neuroscience. As of June 2024, the United Nations reported that 107 countries, accounting for approximately 82% of global greenhouse gas emissions, have committed to net-zero pledges. This commitment is stimulating demand for advanced energy storage systems, which in turn is accelerating the growth of the lithium carbonate market. The steady growth of the pharmaceutical-grade lithium carbonate market reflects the expansion of the pharmaceutical sector and the increasing recognition of lithium-based treatments for mood disorders.

Several key drivers are contributing to this growth, such as the rising prevalence of mood disorders, growing research and development activities, and the increasing adoption of lithium carbonate in pharmaceutical formulations. A significant factor in this market's expansion is the growing awareness of mental health issues. With increasing discussions around mental health and initiatives aimed at tackling these challenges, more people are being diagnosed, which is driving demand for effective medications, including lithium carbonate.

Additionally, the aging global population is contributing to increased demand for pharmaceuticals like lithium carbonate, as mood disorders are more common among older individuals. Ongoing research into lithium's potential applications in neuroscience and psychiatric medicine further supports the market's growth. According to a June 2022 report by the World Health Organization, one in eight people globally experiences a mental disorder that disrupts thinking, emotional regulation, or behavior.

Key Market Drivers

Rising Mental Health Awareness

The pharmaceutical-grade lithium carbonate market is experiencing notable growth, largely driven by the increasing awareness of mental health issues. Lithium carbonate, primarily used to manage bipolar disorder, has gained attention as mental health awareness spreads and more individuals seek treatment for mood disorders. The increased recognition and the subsequent demand for lithium carbonate are crucial drivers of market expansion.

In recent years, there has been a significant shift in societal attitudes toward mental health, with greater emphasis on openly addressing and effectively managing mental health challenges. Advocacy campaigns, educational initiatives, and personal stories have contributed to reducing the stigma surrounding mental health conditions, encouraging individuals to seek help. As a result, more people are being diagnosed with mood disorders, depression, and bipolar disorder, further boosting demand for pharmaceutical treatments like lithium carbonate.

In May 2023, Livent announced a merger agreement with Allkem, a specialty lithium chemicals company, to form NewCo, a leading global producer of lithium chemicals. This merger will provide a diversified portfolio of low-cost assets across key geographies, product segments, and customer bases, with the deal expected to be finalized by the end of 2023.

Key Market Challenges

Side Effects and Safety Concerns

Safety concerns and potential side effects pose significant challenges to the global pharmaceutical-grade lithium carbonate market. While lithium carbonate offers substantial therapeutic benefits, particularly in the treatment of bipolar disorder and other mental health conditions, it is not without its challenges. Potential side effects can include gastrointestinal discomfort, tremors, and in some rare cases, kidney problems or thyroid dysfunction.

These side effects, along with the need for careful monitoring, require healthcare providers and patients to approach lithium treatment with caution. Furthermore, regulatory agencies around the world have implemented stringent monitoring and reporting requirements, adding complexity and cost to its pharmaceutical use. To address these challenges, the pharmaceutical-grade lithium carbonate market must focus on research and development to minimize side effects and enhance drug delivery systems. Additionally, educational initiatives should ensure safe and effective use, and ongoing collaboration between healthcare professionals, patients, and regulatory authorities is vital to balancing therapeutic benefits with safety.

Key Market Trends

Neuroprotective Applications

Research into the neuroprotective applications of lithium carbonate has emerged as a key trend in the global pharmaceutical-grade lithium carbonate market. Lithium carbonate, traditionally used in psychiatric treatment, is gaining attention for its potential neuroprotective properties. This trend is driven by the growing understanding of lithium's therapeutic benefits beyond its traditional role in managing mood disorders.

Researchers and pharmaceutical companies are increasingly exploring lithium carbonate's potential to protect neurons and potentially slow the progression of neurodegenerative diseases like Alzheimer's and Parkinson's disease. Studies suggest that lithium may influence various neuroprotective mechanisms, including reducing inflammation, promoting neurogenesis, and modulating neurotransmitter levels. As a result, there has been an increase in research and development investments aimed at creating lithium carbonate formulations specifically designed for neuroprotection.

With the global population aging and the incidence of neurodegenerative diseases rising, the demand for effective treatments and interventions continues to grow. The exploration of lithium carbonate's neuroprotective applications presents a promising opportunity for both pharmaceutical companies and patients seeking innovative therapies for neurological disorders. While further research is needed to fully understand its potential, the focus on neuroprotective properties highlights the dynamic nature of the pharmaceutical-grade lithium carbonate market and its potential to revolutionize the treatment of neurodegenerative diseases in the future.

Key Market Players

• Arcadium Lithium PLC
• Albemarle Corporation
• Jiangsu Lianhuan Pharmaceutical Co., Ltd.
• American Elements
• Jiangsu Nhwa Pharmaceutical Co., Ltd.
• Panchsheel Organics Ltd (POLTD)
• Blanver

Report Scope

This report segments the Global Pharmaceutical Grade Lithium Carbonate Market into the following categories, along with an analysis of the key industry trends:

By Purity:

• 99%
• Above 99%

By Application:

• Extended Release
• Immediate Release

By Region:

• North America (United States, Canada, Mexico)
• Europe (France, United Kingdom, Italy, Germany, Spain)
• Asia-Pacific (China, India, Japan, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape

This section provides a detailed analysis of the major companies operating in the global pharmaceutical-grade lithium carbonate market.

Available Customizations

TechSci Research offers customized solutions for the global pharmaceutical-grade lithium carbonate market report to meet specific business needs.

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Grade Lithium Carbonate Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Purity (99%, Above 99%)
  • 5.2.2. By Application (Extended Release, Immediate Release)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Pharmaceutical Grade Lithium Carbonate Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Purity
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Purity
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Purity
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Purity
      • 6.3.3.2.2. By Application

7. Europe Pharmaceutical Grade Lithium Carbonate Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Purity
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Purity
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Purity
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Purity
      • 7.3.3.2.2. By Application
  • 7.3.4. France Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Purity
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Purity
      • 7.3.5.2.2. By Application

8. Asia-Pacific Pharmaceutical Grade Lithium Carbonate Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Purity
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Purity
      • 8.3.1.2.2. By Application
  • 8.3.2. India Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Purity
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Purity
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Purity
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Purity
      • 8.3.5.2.2. By Application

9. South America Pharmaceutical Grade Lithium Carbonate Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Purity
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Purity
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Purity
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Purity
      • 9.3.3.2.2. By Application

10. Middle East and Africa Pharmaceutical Grade Lithium Carbonate Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Purity
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Purity
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Purity
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Purity
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Arcadium Lithium PLC
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Albemarle Corporation
• 14.3. Jiangsu Lianhuan Pharmaceutical Co., Ltd.
• 14.4. American Elements
• 14.5. Jiangsu Nhwa Pharmaceutical Co., Ltd.
• 14.6. Panchsheel Organics Ltd (POLTD)
• 14.7. Blanver

15. Strategic Recommendations

16. About Us & Disclaimer